Y Graïc

816 total citations
22 papers, 612 citations indexed

About

Y Graïc is a scholar working on Pathology and Forensic Medicine, Cancer Research and Oncology. According to data from OpenAlex, Y Graïc has authored 22 papers receiving a total of 612 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 12 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Y Graïc's work include Breast Cancer Treatment Studies (12 papers), Cancer Treatment and Pharmacology (7 papers) and Breast Lesions and Carcinomas (6 papers). Y Graïc is often cited by papers focused on Breast Cancer Treatment Studies (12 papers), Cancer Treatment and Pharmacology (7 papers) and Breast Lesions and Carcinomas (6 papers). Y Graïc collaborates with scholars based in France, United States and Italy. Y Graïc's co-authors include B. De Lafontan, P Bastit, Jean-Marie Dilhuydy, B. Cutuli, A Kunlin, Corinne Veyret, J. Tortochaux, M Lacroze, M. Resbeut and Thomas Nguyen and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

Y Graïc

22 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y Graïc France 11 264 262 214 214 213 22 612
Alberto Massocco Italy 10 179 0.7× 50 0.2× 65 0.3× 167 0.8× 66 0.3× 12 372
Jeri S. Akins United States 10 665 2.5× 73 0.3× 103 0.5× 242 1.1× 63 0.3× 12 810
Piotr Skotnicki Poland 12 98 0.4× 35 0.1× 69 0.3× 135 0.6× 50 0.2× 31 392
J. R. Vilcoq France 8 347 1.3× 20 0.1× 52 0.2× 165 0.8× 52 0.2× 19 513
İsmet Taşdelen Türkiye 14 186 0.7× 18 0.1× 42 0.2× 135 0.6× 62 0.3× 28 408
Samuel G.W. Ow Singapore 12 128 0.5× 22 0.1× 40 0.2× 255 1.2× 38 0.2× 50 426
Mario Federico Spain 13 29 0.1× 97 0.4× 73 0.3× 85 0.4× 82 0.4× 29 570
Pietro Del Medico Italy 9 33 0.1× 52 0.2× 46 0.2× 207 1.0× 51 0.2× 15 420
Erin Cordeiro Canada 15 215 0.8× 31 0.1× 34 0.2× 229 1.1× 31 0.1× 34 497
C P Hinton United Kingdom 11 163 0.6× 15 0.1× 46 0.2× 158 0.7× 32 0.2× 20 430

Countries citing papers authored by Y Graïc

Since Specialization
Citations

This map shows the geographic impact of Y Graïc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Graïc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Graïc more than expected).

Fields of papers citing papers by Y Graïc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y Graïc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Graïc. The network helps show where Y Graïc may publish in the future.

Co-authorship network of co-authors of Y Graïc

This figure shows the co-authorship network connecting the top 25 collaborators of Y Graïc. A scholar is included among the top collaborators of Y Graïc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y Graïc. Y Graïc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rouëssé, Jacques, Brigitte De La Lande, F. Bertheault-Cvitkovic, et al.. (2006). A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: Final results. International Journal of Radiation Oncology*Biology*Physics. 64(4). 1072–1080. 53 indexed citations
5.
Cutuli, B., Christian Borel, F. Dhermain, et al.. (2001). Breast cancer occurred after treatment for Hodgkin's disease: analysis of 133 cases. Radiotherapy and Oncology. 59(3). 247–255. 66 indexed citations
6.
Noguès, Catherine, D. Serin, Y Graïc, et al.. (1998). Sequential or simultaneous chemo-radiotherapy in operable breast cancer. A French multicentric phase III study — State of inclusions. European Journal of Cancer. 34. S44–S45. 3 indexed citations
7.
Boccara, Claude, et al.. (1998). Apport du CA 15.3 en cancérologie mammaire. Immuno-analyse & Biologie Spécialisée. 13(1). 19–25. 3 indexed citations
8.
Vialard, François, J P Basuyau, Joseph Gligorov, et al.. (1998). CA-15.3: Prognostic factor in breast cancer. European Journal of Cancer. 34. S100–S100. 1 indexed citations
9.
Cutuli, B., Anne de la Rochefordière, F. Dhermain, et al.. (1997). Cancer du sein bilatéral après maladie de Hodgkin. Particularités clinico-histologiques et possibilités thérapeutiques: analyse de 13 cas. Cancer/Radiothérapie. 1(4). 300–306. 16 indexed citations
10.
Dhermain, F., Christian Borel, Y Graïc, et al.. (1997). Breast cancer in patients treated for hodgkin’s disease: clinical and pathological analysis of 76 cases in 63 patients. European Journal of Cancer. 33(14). 2315–2320. 26 indexed citations
11.
Cutuli, B., M Lacroze, Jean-Marie Dilhuydy, et al.. (1995). Male breast cancer: Results of the treatments and prognostic factors in 397 cases. European Journal of Cancer. 31(12). 1960–1964. 164 indexed citations
12.
Chevallier, B, P Bastit, Y Graïc, et al.. (1993). The Centre H. Becquerel studies in inflammatory non metastatic breast cancer. Combined modality approach in 178 patients. British Journal of Cancer. 67(3). 594–601. 46 indexed citations
13.
Chevallier, B, et al.. (1993). VP-16, Cisplatin, Doxorubicin, and Bleomycin in Metastatic Merkel Cell Carcinoma. American Journal of Clinical Oncology. 16(2). 102–104. 21 indexed citations
14.
Lacroze, M, et al.. (1992). [Breast cancer in males: a study of 15 cases of pure ductal carcinoma in situ].. PubMed. 79(11). 1045–53. 7 indexed citations
15.
Lacroze, M, Jean-Marie Dilhuydy, Markus Velten, et al.. (1992). [Breast cancer in men: incidence and types of associated previous synchronous and metachronous cancers].. PubMed. 79(7). 689–96. 12 indexed citations
16.
Chevallier, B, et al.. (1989). [What are the prognostic factors in operable breast cancer without histologic axillary lymph node invasiveness. Results of an uni- and multifactorial analysis].. PubMed. 76(1). 51–60. 2 indexed citations
17.
Chevallier, B, et al.. (1988). [Prognostic value of estrogen and progesterone receptors in the operable breast cancer: results of a uni- and multifactorial analysis].. PubMed. 75(1). 23–36. 2 indexed citations
18.
Chevallier, Bernard, Bernard Asselain, A Kunlin, et al.. (1987). Inflammatory breast cancer. Determination of prognostic factors by univariate and multivariate analysis. Cancer. 60(4). 897–902. 63 indexed citations
19.
Delozier, T., et al.. (1986). Adjuvant tamoxifen in postmenopausal breast cancer: Preliminary results of a randomized trial. Breast Cancer Research and Treatment. 7(2). 105–109. 39 indexed citations
20.
Calle, Roberto A., Y Graïc, A Mazabraud, & P Schlienger. (1974). [Solitary osseous plasmacytoma. Apropos of 4 cases].. PubMed. 59(4). 395–403. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026